NASDAQ
Prime Medicine, Inc. (PRME) has a fcf yield of -32.37% as of Monday, August 3, 2026. This represents a 85.03% decrease compared to its 12-month average of -17.49%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.